A total of 7 institutions have reported a stake in Bright Minds Biosciences Inc. (NASDAQ:DRUG) as of December 2025, according to recent 13F filings with the SEC.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 30 Sep, 2025 | 1,145,660 | 0 | 0.00% | $69,134,853.00 |
| Cormorant Asset Management, LP | 30 Sep, 2025 | 1,059,331 | 0 | 0.00% | $64,259,018.00 |
| Vivo Capital, LLC | 30 Sep, 2025 | 501,617 | 250,045 | 99.39% | $30,428,087.00 |
| Commodore Capital LP | 30 Sep, 2025 | 500,000 | 0 | 0.00% | $30,330,000.00 |
| PERCEPTIVE ADVISORS LLC | 30 Sep, 2025 | 449,290 | 28,600 | 6.80% | $27,253,931.00 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 30 Sep, 2025 | 395,743 | 195,743 | 97.87% | $24,005,770.00 |
| BRAIDWELL LP | 30 Sep, 2025 | 303,685 | 303,685 | 0.00% | $18,421,532.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 234,118 | 24,441 | 11.66% | $14,201,598.00 |
| MORGAN STANLEY | 30 Sep, 2025 | 192,866 | 30,797 | 19.00% | $11,699,251.00 |
| Sio Capital Management, LLC | 30 Sep, 2025 | 190,764 | -321,574 | -62.77% | $11,571,744.00 |
| BALYASNY ASSET MANAGEMENT L.P. | 30 Sep, 2025 | 186,922 | 186,922 | 0.00% | $11,338,689.00 |
| Point72 Asset Management, L.P. | 30 Sep, 2025 | 105,020 | -30,000 | -22.22% | $6,370,513.00 |
| ACUTA CAPITAL PARTNERS, LLC | 30 Sep, 2025 | 84,875 | 36,401 | 75.09% | $5,148,518.00 |
| MILLENNIUM MANAGEMENT LLC | 30 Sep, 2025 | 76,681 | -34,690 | -31.15% | $4,651,469.00 |
| Walleye Capital LLC | 30 Sep, 2025 | 72,754 | 19,324 | 36.17% | $4,413,258.00 |
| STATE STREET CORP | 30 Sep, 2025 | 68,388 | 43,733 | 177.38% | $4,148,416.00 |
| Schonfeld Strategic Advisors LLC | 30 Sep, 2025 | 66,606 | -2,398 | -3.48% | $4,040,317.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 57,899 | 378 | 0.66% | $3,512,152.00 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 30 Sep, 2025 | 53,950 | 53,950 | 0.00% | $3,272,607.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 45,103 | 13,120 | 41.02% | $2,735,947.00 |